APTOSE BIOSCIENCES INC (APTO)

CA03835T3091 - Common Stock

0.19  -0.05 (-22.13%)

After market: 0.172 -0.02 (-9.47%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to APTO. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 14.79. This target is 7684.21% above the current price.
APTO was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about APTO.
In the previous month the buy percentage consensus was at a similar level.
APTO was analyzed by 8 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 0.196.0614.7914.7924.15 - 3,089.47% 7,684.21% 7,684.21% 12,610.53%
Up and Down Grades
Date Firm Action Rating
2024-11-20 HC Wainwright & Co. Maintains Buy -> Buy
2024-06-14 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-16 Canaccord Genuity Maintains Buy -> Buy
2024-04-03 Piper Sandler Maintains Overweight -> Overweight
2024-03-27 HC Wainwright & Co. Maintains Buy -> Buy
2024-02-01 Piper Sandler Maintains Overweight -> Overweight
2023-11-10 RBC Capital Maintains Outperform -> Outperform
2023-09-07 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-08-11 Oppenheimer Maintains Outperform -> Outperform
2023-08-11 RBC Capital Maintains Outperform -> Outperform
2023-08-11 Piper Sandler Maintains Overweight -> Overweight
2023-08-11 HC Wainwright & Co. Maintains Buy -> Buy
2023-06-12 Cantor Fitzgerald Maintains Overweight
2023-06-12 Oppenheimer Maintains Outperform -> Outperform
2023-06-12 HC Wainwright & Co. Maintains Buy -> Buy
2023-06-07 RBC Capital Maintains Outperform -> Outperform
2023-06-07 Piper Sandler Maintains Overweight -> Overweight
2023-05-09 Oppenheimer Reiterate Outperform
2023-05-09 RBC Capital Reiterate Outperform
2023-05-09 HC Wainwright & Co. Reiterate Buy
2023-03-27 Canaccord Genuity Maintains Buy
2023-03-24 RBC Capital Reiterate Outperform
2022-11-02 RBC Capital Maintains Outperform
2022-05-10 RBC Capital Maintains Outperform
2021-12-21 HC Wainwright & Co. Maintains Buy
2021-11-12 HC Wainwright & Co. Maintains Buy